1. Home
  2. FEMY vs IHT Comparison

FEMY vs IHT Comparison

Compare FEMY & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

SELL

Current Price

$1.22

Market Cap

11.5M

Sector

Health Care

ML Signal

SELL

Logo InnSuites Hospitality Trust Shares of Beneficial Interest

IHT

InnSuites Hospitality Trust Shares of Beneficial Interest

SELL

Current Price

$1.01

Market Cap

11.8M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
FEMY
IHT
Founded
2004
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
11.8M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
FEMY
IHT
Price
$1.22
$1.01
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $14.75
N/A
AVG Volume (30 Days)
★ 104.8K
17.8K
Earning Date
11-13-2026
09-16-2026
Dividend Yield
N/A
★ 1.98%
EPS Growth
★ 44.71
N/A
EPS
N/A
★ N/A
Revenue
$2,293,313.00
★ $7,600,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$294.61
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 40.77
1.33
52 Week Low
$0.29
$0.93
52 Week High
$6.29
$1.90

Technical Indicators

Market Signals
Indicator
FEMY
IHT
Relative Strength Index (RSI) 36.99 43.89
Support Level $0.33 $1.01
Resistance Level $1.55 $1.12
Average True Range (ATR) 0.14 0.06
MACD 0.01 0.01
Stochastic Oscillator 36.46 64.43

Price Performance

Historical Comparison
FEMY
IHT

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About IHT InnSuites Hospitality Trust Shares of Beneficial Interest

InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns interests in two hotels, operates and provides management services, and provides trademark license services, for two hotels. The Trust also holds an investment related to clean energy electricity generation technology and manages an option to acquire an investment in an independent boutique hotel reservation and hotel services business.

Share on Social Networks: